熱門資訊> 正文
2020-04-23 21:00
April 23 (Reuters) - Pfenex Inc :
* PFENEX INC - ENTERED INTO A DEED OF ASSIGNMENT AND AMENDMENT WITH NT PHARMA, NT INTERNATIONAL AND KANGCHEN
* PFENEX INC - AGREED TO ALLOW NT PHARMA TO ASSIGN ITS RIGHTS AND OBLIGATIONS UNDER DEVELOPMENT AND LICENSE AGREEMENT WITH CO TO KANGCHEN
* PFENEX INC - NT PHARMA, THROUGH NT INTERNATIONAL, WILL OBTAIN AN EQUITY INTEREST IN KANGCHEN
* PFENEX INC - LICENSE AGREEMENT WAS ORIGINALLY ENTERED INTO ON APRIL 18, 2018
Source : () Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)